Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report) shares were up 9.2% on Friday. The stock traded as high as $0.84 and last traded at $0.84. Approximately 100 shares were traded during mid-day trading, a decline of 99% from the average session volume of 9,053 shares. The stock had previously closed at $0.7692.
Peak Pharmaceuticals Price Performance
The company’s fifty day simple moving average is $0.87 and its 200-day simple moving average is $1.16.
Peak Pharmaceuticals Company Profile
Peak Pharmaceuticals, Inc. was a biotechnology company focused on developing natural product-based treatments for metabolic disorders. Its work centered on research and development rather than a broad portfolio of marketed medicines. Publicly available information about the company’s specific products, operating history, geographic reach and leadership is limited, so those details cannot be described reliably.
Further Reading
- Five stocks we like better than Peak Pharmaceuticals
- Bargain Hunting: Why Off-Price Retail Is Winning
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
